Zhang et al. found in the cell model that inhibiting BRD4 exacerbates pathological changes in Alzheimer’s disease (AD), leading to Aβ increased sedimentation (Zhang et al., 2022). Here, BRD4 is linked to early-onset autosomal dominant Alzheimer disease.